H. M. Moulton, Wu, B., Jearawiriyapaisarn, N., Sazani, P., Lu, Q. Long, and Kole, R.
, “Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy.”
, Annals of the New York Academy of Sciences
, vol. 1175, pp. 55-60, 2009.
H. M. Moulton, Nelson, M. H., Hatlevig, S. A., Reddy, M. T., and Iversen, P. L.
, “Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.”
, Bioconjugate chemistry
, vol. 15, no. 2, pp. 290-9, 2004.
H. M. Moulton, Hase, M. C., Smith, K. M., and Iversen, P. L.
, “HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.”
, Antisense & nucleic acid drug development
, vol. 13, no. 1, pp. 31-43, 2003.
H. M. Moulton, Yoshihara, P. H., Mason, D. H., Iversen, P. L., and Triozzi, P. L.
, “Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.”
, Clinical cancer research : an official journal of the American Association for Cancer Research
, vol. 8, no. 7, pp. 2044-51, 2002.